Literature DB >> 23807386

Subconjunctival anaesthesia for intravitreal injections.

P Alexander1, D Sahu, A J Lotery.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23807386      PMCID： PMC3772366          DOI： 10.1038/eye.2013.132

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN： 0950-222X            Impact factor:   3.775


× No keyword cloud information.
  3 in total

1.  Ocular complications after anti-vascular endothelial growth factor therapy in Medicare patients with age-related macular degeneration.

Authors:  Shelley Day; Kofi Acquah; Prithvi Mruthyunjaya; Daniel S Grossman; Paul P Lee; Frank A Sloan
Journal:  Am J Ophthalmol       Date:  2011-06-12       Impact factor: 5.258

2.  Meta-analysis of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents: causative organisms and possible prevention strategies.

Authors:  Colin A McCannel
Journal:  Retina       Date:  2011-04       Impact factor: 4.256

3.  Post-intravitreal anti-VEGF endophthalmitis in the United Kingdom: incidence, features, risk factors, and outcomes.

Authors:  D A M Lyall; A Tey; B Foot; S T D Roxburgh; M Virdi; C Robertson; C J MacEwen
Journal:  Eye (Lond)       Date:  2012-10-12       Impact factor: 3.775
  3 in total
  1 in total

1.  Reply to Alexander et al (Subconjunctival anaesthesia for intravitreal injections).

Authors:  D A M Lyall; A Tey; B Foot; S T D Roxburgh; M Virdi; C Robertson; C J MacEwen
Journal:  Eye (Lond)       Date:  2013-06-28       Impact factor: 3.775
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.